Home › Non-Small Cell Lung Cancer › New York › Shirley
Non-Small Cell Lung Cancer clinical trials in Shirley, NY
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Shirley (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RecruitingPhase 1/2
- New York Cancer And Blood Specialists - Shirley /ID# 272547, Shirley
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- New York Cancer and Blood Specialists, Shirley
Pan-tumor MRD Study
RecruitingObservational study
- New York Cancer & Blood Specialists, Shirley
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Shirley
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Riverhead · 13 mi away
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- New York Cancer & Blood Specialists (NYCBS), Shirley
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Shirley
- Colorectal Cancer6 studies
- Cardiovascular Disease4 studies
- Breast Cancer3 studies
- Metastatic Cancer3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.